Accessibility Menu
Aimei Health Technology logo

Aimei Health Technology(NASDAQ) AFJK

Current Price$11.76
Market Cap$37.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2024)+17%
5 YearN/A
1 Year+6%
1 Month-61%
Aimei Health Technology last closing stock price
MetricPriceDate
Last closeUSD 11.902026-07-23
Aimei Health Technology stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.83%USD 12.002026-07-16
1 month-61.49%USD 30.902026-06-23
3 month-74.79%USD 47.202026-04-24
Year to date-81.41%USD 64.012025-12-31
1 year+5.78%USD 11.252025-07-23
Since inception+17.24%USD 10.152024-01-22

Aimei Health Technology Financials at a Glance

Market Cap

$37.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

$920.55K

EPS (TTM)

$0.17

P/E Ratio

72.08

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Price

$11.76

Volume

145

Open

$11.97

Previous Close

$11.76

Daily Range

$11.76 - $11.99

52-Week Range

$6.75 - $130.37

Estimated Earnings Date

May 4, 2026

AFJK News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aimei Health Technology

Aimei helps medical companies list on the stock market. It searches for businesses that make new medicines and devices. This gives private firms a way to reach public investors.

A Vehicle for Acquisitions

  • Target Search: Finding smaller businesses in the medical and diagnostic sectors; focused on targets in North America, Europe, and Asia.
  • Business Combination: Planning to merge with or buy other companies; acts as a shell company to help private entities join the public market.
  • Sector Focus: Evaluating prospects in the biopharmaceutical and medical technology industries; aims to support businesses that have proprietary technology.

The Path to United Hydrogen

  • Signed a definitive business combination agreement with United Hydrogen Group Inc. in June 2024.
  • Executed an amendment in February 2025 to extend the deadline for completing an initial business combination.
  • Submitted required regulatory materials to the China Securities Regulatory Commission regarding the pending deal.
  • Planned a merger involving United Hydrogen Global Inc. and specialized subsidiaries to form a new public holding company.

Sourcing Healthcare Innovation

The management team has decades of experience in financial oversight and operating companies in Asian markets. This background helps Aimei find healthcare targets with high growth potential.

Measuring the Money

  • Operating income reached -$250,589 in Q4 2025, narrowing its loss by 37.7% from Q4 2024.
  • Net income was $98,117 in Q4 2025, down 77.9% from the prior year.
  • Market capitalization reached $259.1 million in Q4 2025, up 168.3% year-over-year.
  • Free cash flow hit -$43,232 in Q4 2025, narrowing the loss by 77.8% from Q4 2024.

Bottom Line

Aimei is moving from a shell company toward an active business through its merger with United Hydrogen. Its long-term relevance depends on completing this transaction before the May 2026 deadline.

AI Generated • May 13, 2026

Industry

Capital Markets

Sector

Financials

Employees

2

CEO

Jun Heng Xie

Headquarters

New York City, NY 10022, US

AFJK Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

3.69%

Return on Capital

-8.30%

Return on Assets

7.49%

Earnings Yield

1.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$37.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

3.17M

Volume

145

Avg. Volume

12.04K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$484.33K

EBITDA

-$484.33K

Operating Cash Flow

-$415.70K

Capital Expenditure

$0.00

Free Cash Flow

-$415.70K

Cash & ST Invst.

$18.52K

Total Debt

$2.09M

Aimei Health Technology Performance Analysis

Aimei Health Technology annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Aimei Health Technology sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Aimei Health Technology annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-12-31USD 0.02N/A
20242024-12-31USD 0.281388.4%
20252025-12-31USD 0.17-39.3%
Aimei Health Technology sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30238.5%
Q32025-09-30-13.5%
Q42025-12-31-60.3%
Q12026-03-31-39.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$37.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$18.84M

N/A

Employees

2

N/A

Net Income

$45.44K

-75.4%

EBITDA

-$61.98K

+85.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$18.52K

+152.1%

Total Debt

$2.09M

+177.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$2.09M

+177.0%

Return on Assets

7.49%

N/A

Return on Invested Capital

-5.52%

N/A

Free Cash Flow

-$74.61K

+66.7%

Operating Cash Flow

-$74.61K

+66.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RIBBRibbon Acquisition Corp
$10.81+0.03%
RIBBURibbon Acquisition Corp.
$10.73+0.00%
OAKUOak Woods Acquisition Corporation
$12.20+0.00%
ORIQUOrigin Investment Corp I Units
$10.35+3.29%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%

Questions About AFJK

What is the current price of Aimei Health Technology?

Aimei Health Technology is trading at $11.76 per share.

What is the 52-week range for Aimei Health Technology?

Over the past 52 weeks, Aimei Health Technology has traded between $6.75 and $130.37.

How much debt does Aimei Health Technology have?

As of the most recent reporting period, Aimei Health Technology reported total debt of $2.09M.

How much cash does Aimei Health Technology have on hand?

Aimei Health Technology reported $18.52K in cash and cash equivalents in its most recent financial results.

What is Aimei Health Technology’s dividend yield?

Aimei Health Technology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services